The evolvement of coronavirus variants is socially unacceptable but understandable in a
world that has grown tired of playing defence against “severe acute respiratory syndrome …

Coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has been spreading worldwide since its outbreak in December 2019, and …

Purpose The purpose of current review is to conduct a systematic overview of articles
published between 2019 and 2021 on the relationship of comorbidities and mortality due to …

Background Monoclonal antibody treatment may prevent complications of coronavirus
disease 2019 (COVID-19). We sought to quantify the impact of bamlanivimab monoclonal …

Background Prospective population-based studies investigating multiple determinants of pre-
vaccination antibody responses to SARS-CoV-2 are lacking. Methods We did a prospective …

NLRP3 inflammasome is a critical immune component that plays a crucial role in mounting
innate immune responses. The deleterious effects of inflammasome activation have been …

The COVID-19 pandemic caused much illness, many deaths, and profound disruption to
society. The production of 'safe and effective'vaccines was a key public health target. Sadly …

The aim of this study was to assess the long-term dynamics and factors associated with the
serological response against the severe acute respiratory syndrome coronavirus 2 after …

Objective: To determine whether time elapsed since the second BNT162b2 messenger RNA
(mRNA) vaccine (Pfizer-BioNTech) injection is significantly associated with the risk of post …

Rationale: There are limited therapeutic options for patients with coronavirus disease
(COVID-19)-related acute respiratory distress syndrome with inflammation-mediated lung …